Shanghai Medicilon Inc (688202) — Financial Flexibility Index
Shanghai Medicilon Inc (688202) has a Financial Flexibility Index of 0.04x as of June 2023. Free cash flow of CN¥30.88 Million (operating CF CN¥-17.10 Million minus capex CN¥47.98 Million) represents 0% of total liabilities (CN¥860.98 Million). Check total reinvestment intensity of Shanghai Medicilon Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Medicilon Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Shanghai Medicilon Inc across 10 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Shanghai Medicilon Inc.
Annual Financial Flexibility Index for Shanghai Medicilon Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Shanghai Medicilon Inc. Explore debt repayment capacity of Shanghai Medicilon Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | CN¥174.21 Million | CN¥105.17 Million | CN¥687.85 Million | ▲ +97.4% |
| 2024 | 0.13x | CN¥87.64 Million | CN¥-22.75 Million | CN¥683.10 Million | ▼ -70.9% |
| 2023 | 0.44x | CN¥333.42 Million | CN¥33.32 Million | CN¥755.07 Million | ▼ -16.1% |
| 2022 | 0.53x | CN¥382.73 Million | CN¥-21.33 Million | CN¥726.80 Million | ▼ -67.1% |
| 2021 | 1.60x | CN¥745.65 Million | CN¥452.94 Million | CN¥466.06 Million | ▲ +12.1% |
| 2020 | 1.43x | CN¥326.49 Million | CN¥207.77 Million | CN¥228.67 Million | ▲ +17.1% |
| 2019 | 1.22x | CN¥155.68 Million | CN¥58.30 Million | CN¥127.73 Million | ▲ +12.5% |
| 2018 | 1.08x | CN¥135.48 Million | CN¥71.11 Million | CN¥125.06 Million | ▼ -17.1% |
| 2017 | 1.31x | CN¥133.61 Million | CN¥74.70 Million | CN¥102.29 Million | ▲ +75.7% |
| 2016 | 0.74x | CN¥73.44 Million | CN¥34.13 Million | CN¥98.81 Million | — |